Home

MetLife Inc (MET)

NYSE · Financials · Insurance

MetLife shares are trading at $73.88, down roughly 9% from their 52-week high of $83.25 reached in late 2025. The stock found support near $67.70 in late March 2026 before bouncing. At a trailing P/E of 15.7x and forward P/E of 8.2x, valuation remains moderate relative to the broader market, with a 3.0% dividend yield providing income support.

About This Report

This research was independently produced by multiple AI models analyzing the same underlying data. Each model read MetLife's SEC filings (10-K, 10-Q, 8-K, DEF 14A), earnings data, financial statements, and peer comparisons — then formed its own conclusions.

Sections

Business — How MetLife operates across its insurance, annuities, and employee benefits segments; competitive positioning among global insurers

Numbers — Revenue trends, profitability, capital adequacy, valuation multiples, and peer comparison with PRU, AFL, LNC, PFG, UNM

People — Management team, board governance, executive compensation, and insider alignment

Story — Narrative evolution from earnings calls and filings, credibility of forward guidance, risk factor changes

Verdict — Catalysts, risks, buy/hold/sell framework, scenario analysis, and options strategies